Capricor Therapeutics Income Statement (2010-2026) | CAPR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.20M					1.59M	0.96M	2.99M	3.92M	6.19M	12.09M	10.00M	3.97M	2.26M	11.13M
Operating items
Research & Development (Quarter)	3.50M	2.50M	4.30M	5.12M	4.97M	5.50M	6.23M	7.66M	8.82M	10.03M	9.95M	11.10M	12.50M	11.81M	14.57M	18.92M	22.00M	20.36M	23.15M	27.38M
Selling, General & Administrative (Quarter)	1.79M	1.80M	2.12M	2.72M	2.36M	2.56M	2.79M	3.51M	2.85M	3.02M	3.43M	4.07M	3.06M	3.46M	4.27M	6.07M	5.67M	5.92M	6.02M	9.40M
Restructuring Costs (Quarter)														1.14M				2.61M
Other Operating Expenses (Quarter)	-0.00M	0.01M	-0.04M				-0.03M			-0.01M	-653.00		0.00M	-1.14M	-0.01M	-0.15M		-0.01M		-0.08M
Operating Expenses (Quarter)	5.29M	4.31M	6.38M	7.83M	7.32M	8.07M	9.03M	11.17M	11.66M	13.05M	13.37M	15.17M	15.56M	15.27M	18.83M	24.98M	27.72M	26.28M	29.16M	36.77M
Operating Income (Quarter)	-5.08M	-4.31M	-6.38M	-7.83M	-7.32M	-6.48M	-8.07M	-8.18M	-7.75M	-6.86M	-1.28M	-10.27M	-11.59M	-13.01M	26.37M	-24.98M	-27.72M	-26.28M	-29.16M	-36.77M
EBIT (Quarter)	-5.08M	-4.31M	-6.38M	-7.83M	-7.32M	-6.48M	-8.07M	-8.18M	-7.75M	-6.86M	-1.28M	-10.27M	-11.59M	-13.01M	26.37M	-24.98M	-27.72M	-26.28M	-29.16M	-36.77M
Non-operating items
Interest & Investment Income (Quarter)	0.02M	0.02M	0.02M	0.01M	0.02M	0.11M	0.38M	0.42M	0.38M	0.48M	0.45M	0.47M	0.59M	0.45M	0.69M	0.73M	1.79M	1.71M	2.02M	2.90M
Other Non Operating Income (Quarter)	0.32M															-0.14M				-0.07M
Non Operating Income (Quarter)	0.33M	0.38M	0.19M	0.01M	0.21M	0.11M	0.35M	0.42M	0.38M	0.47M	0.52M	0.47M	0.59M	0.45M	0.58M	0.59M	1.81M	1.71M	-1.01M	2.83M
Net income details
EBT (Quarter)	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	27.06M	-24.39M	-25.93M	-24.57M	-27.13M	-33.94M
Profit After Tax (Quarter)	-4.75M	-3.93M	-6.19M	-7.82M	-7.11M	-6.37M	-7.72M	-7.77M	-7.37M	-6.39M	-0.76M	-9.79M	-11.00M	-12.56M	-7.12M	-24.39M	-25.91M	-24.57M	-30.17M	-33.94M
Income from Continuing Operations (Quarter)	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	27.06M	-24.39M	-25.93M	-24.57M	-27.13M	-33.94M
Consolidated Net Income (Quarter)	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	27.06M	-24.39M	-25.93M	-24.57M	-27.13M	-33.94M
Income towards Parent Company (Quarter)	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	27.06M	-24.39M	-25.93M	-24.57M	-27.13M	-33.94M
Net Income towards Common Stockholders (Quarter)	-5.07M	-4.30M	-6.36M	-7.82M	-7.30M	-6.37M	-7.69M	-7.77M	-7.37M	-6.39M	-0.83M	-9.79M	-11.00M	-12.56M	27.06M	-24.39M	-25.93M	-24.57M	-27.13M	-33.94M
Additional items
EPS (Basic) (Quarter)	-0.21	-0.17	-0.26	-0.32	-0.29	-0.26	-0.31	-0.31	-0.29	-0.25	0.02	-0.31	-0.35	-0.38	-0.11	-0.53	-0.57	-0.54	-0.62	-0.59
EPS (Weighted Average and Diluted) (Quarter)	-0.21	-0.17	-0.26	-0.32	-0.29	-0.26	-0.31	-0.31	-0.29	-0.25	0.02	-0.31	-0.35	-0.38	-0.11	-0.53	-0.57	-0.54	-0.62	-0.59
Shares Outstanding (Weighted Average) (Quarter)	22.86M	0.13M	0.11M	24.28M	24.32M	0.11M	0.11M	25.25M	25.29M	25.82M	5.04M	31.35M	31.60M	32.10M	35.22M	45.64M	45.67M	45.69M	3.35M	57.43M
Shares Outstanding (Diluted Average) (Quarter)	22.55M	22.73M	23.09M	24.28M	24.30M	24.43M	24.55M	25.25M	25.34M	25.82M	26.78M	31.35M	31.60M	33.09M	35.22M	45.64M	45.71M	45.72M	46.48M	57.43M
EBITDA (Quarter)	-4.75M	-3.93M	-6.17M	-7.82M	-7.09M	-6.30M	-7.72M	-7.80M	-7.28M	-6.50M	-0.64M	-9.72M	-11.20M	-12.60M	-6.18M	-23.60M	-26.30M	-25.10M	-30.74M	-34.50M
Interest Expenses (Quarter)

Research Tools

Developers

Capricor Therapeutics Income Statement (2010-2026) | CAPR

Research Tools

Developers

Capricor Therapeutics Income Statement (2010-2026) | CAPR

Create an account

Sign In

Reset Password